3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Classical hematology
2
Conditions
Neoplasms
3
Venous Thrombosis
2
Venous Thromboembolism
2
Thrombosis
2
Pulmonary Embolism
2
Urinary Tract Infections
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Thromboembolism
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Renal Insufficiency, Chronic
1
Pulmonary Arterial Hypertension
1
Prostatic Neoplasms
1
Pneumonia
1
Pancreatic Neoplasms
1
Pain
1
Neutropenia
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Migraine Disorders
1
Menorrhagia
1
Meningitis, Bacterial
1
Meningitis
1
Intraabdominal Infections
1
Interventions
Dalteparin
9
apixaban
7
Enoxaparin
7
Tinzaparin
5
edoxaban
4
Rivaroxaban
4
Heparin, Low-Molecular-Weight
3
Dabigatran
3
Warfarin
2
Fondaparinux
2
reviparin
1
myotubularin
1
certoparin
1
bemiparin
1
atezolizumab
1
acarboxyprothrombin
1
Ultrasonography, Doppler, Duplex
1
Rosuvastatin Calcium
1
Phenprocoumon
1
Nadroparin
1
Models, Biological
1
Medication Therapy Management
1
Laparoscopy
1
Intermittent Pneumatic Compression Devices
1
Imaging, Three-Dimensional
1
Hospitals
1
Heparin
1
Fluorodeoxyglucose F18
1
Educational Status
1
Data Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Venous Thrombosis
×
Warfarin
×
Clear all
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts
NCT01164046
2014-12-03
Longheva
University Medical Center Groningen
Phase 3
Terminated
56 enrolled